Cannabis pharmacogenomics: a path to personalized medicine

M Babayeva, ZG Loewy - Current Issues in Molecular Biology, 2023 - mdpi.com
Cannabis and related compounds have created significant research interest as a promising
therapy in many disorders. However, the individual therapeutic effects of cannabinoids and …

Use of pharmacogenetics to optimize immunosuppressant therapy in kidney-transplanted patients

V Urzì Brancati, C Scarpignato, L Minutoli, G Pallio - Biomedicines, 2022 - mdpi.com
Immunosuppressant drugs (ISDs) are routinely used in clinical practice to maintain organ
transplant survival. However, these drugs are characterized by a restricted therapeutic …

Pharmacokinetics and toxicokinetics roles of membrane transporters at kidney level

J Veiga-Matos, F Remião… - Journal of Pharmacy & …, 2020 - journals.library.ualberta.ca
Transporters are large membrane proteins, which control the passage of various
compounds through biological membranes. These proteins are divided into uptake and …

Pharmacogenomics of old and new immunosuppressive drugs for precision medicine in kidney transplantation

S Turolo, A Edefonti, ML Syren, G Montini - Journal of Clinical Medicine, 2023 - mdpi.com
Kidney transplantation is the preferred therapeutic option for end-stage kidney disease, but,
despite major therapeutic advancements, allograft rejection continues to endanger graft …

Study Models of Drug–Drug Interactions Involving P-Glycoprotein: The Potential Benefit of P-Glycoprotein Modulation at the Kidney and Intestinal Levels

J Veiga-Matos, AI Morales, M Prieto, F Remião, R Silva - Molecules, 2023 - mdpi.com
P-glycoprotein (P-gp) is a crucial membrane transporter situated on the cell's apical surface,
being responsible for eliminating xenobiotics and endobiotics. P-gp modulators are …

Significance of ethnic factors in immunosuppressive therapy management after organ transplantation

T Yamada, M Zhang, S Masuda - Therapeutic Drug Monitoring, 2020 - journals.lww.com
Clinical outcomes after organ transplantation have greatly improved in the past 2 decades
with the discovery and development of immunosuppressive drugs such as calcineurin …

Influence of TGFB1 and CTLA4 polymorphisms on calcineurin inhibitors dose and risk of acute rejection in renal transplantation

A Bogacz, M Wolek, J Sieńko, B Czerny… - Scientific Reports, 2021 - nature.com
Organ transplant is often the treatment of choice as it extends and improves patient life.
Immunosuppressive treatment, which prevents acute rejection of the organ, is used in …

[HTML][HTML] Self-assembling peptide scaffold carrying neural-cell adhesion molecule-derived mimetic-peptide transplantation promotes proliferation and stimulates …

J Xu, J Feng, Y Liu, T Hu, M Li, F Li - Annals of Transplantation, 2020 - ncbi.nlm.nih.gov
Background Self-assembling peptide scaffolds have been extensively applied in tissue
engineering. Many investigations have modified self-assembling peptide scaffolds by …

[PDF][PDF] 重庆地区儿童CYP450 基因多态性

何小丽, 褚京乐, 何燕 - 临床与病理杂志, 2021 - cdn.amegroups.cn
目的: 了解重庆地区儿童细胞色素氧化酶450 (CYP450) 单核苷酸多态性, 为指导儿童用药提供
支持. 方法: 使用PCR 法检测400 例儿童中CYP2D6 (100C> T), CYP2C9 (1075A> C) …

CYP and SXR gene polymorphisms influence in opposite ways acute rejection rate in pediatric patients with renal transplant

S Turolo, A Edefonti, L Ghio, S Testa, W Morello… - BMC pediatrics, 2020 - Springer
Background We evaluated the role of CYP3A5, ABCB1 and SXR gene polymorphisms in the
occurrence of acute kidney rejection in a cohort of pediatric renal transplant recipients …